Alkem Laboratories Ltd
NSE :ALKEM BSE :539523 Sector : PharmaceuticalsBuy, Sell or Hold ALKEM? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
03 May 4904.00 (2.43%) | 02 May 4787.80 (-0.94%) | 30 Apr 4833.05 (-1.03%) | 29 Apr 4883.50 (-0.55%) | 26 Apr 4910.40 (0.88%) | 25 Apr 4867.65 (3.11%) | 24 Apr 4720.95 (0.35%) | 23 Apr 4704.40 (-0.87%) | 22 Apr 4745.70 (2.80%) | 19 Apr 4616.35 (-0.74%) | 18 Apr 4650.85 (-1.76%) | 16 Apr 4734.30 (0.40%) | 15 Apr 4715.65 (-0.41%) | 12 Apr 4735.20 (-1.85%) | 10 Apr 4824.50 (-1.19%) | 09 Apr 4882.60 (-0.12%) | 08 Apr 4888.35 (-0.49%) | 05 Apr 4912.65 (0.96%) | 04 Apr 4866.10 (-0.58%) | 03 Apr 4894.65 (-1.22%) | 02 Apr 4955.35 (-1.07%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Very Bullish
Medium Term Investors
Bearish
Long Term Investors
Bullish
Moving Averages
5 DMA
Bullish
4860.35
10 DMA
Bullish
4794.07
20 DMA
Bullish
4801.63
50 DMA
Bearish
4968.89
100 DMA
Bearish
5003.94
200 DMA
Bullish
4438.06
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On May 03, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 5137.2 | 5033.6 | 4950.31 | - | - |
R2 | 5033.6 | 4969.27 | 4934.87 | 5043.3 | - |
R1 | 4968.8 | 4929.53 | 4919.44 | 4988.2 | 5001.2 |
P | 4865.2 | 4865.2 | 4865.2 | 4874.9 | 4881.4 |
S1 | 4800.4 | 4800.87 | 4888.56 | 4819.8 | 4832.8 |
S2 | 4696.8 | 4761.13 | 4873.13 | 4706.5 | - |
S3 | 4632 | 4696.8 | 4857.69 | - | - |
Key Metrics
EPS
143.82
P/E
34.07
P/B
5.77
Dividend Yield
1.02%
Market Cap
58,635 Cr.
Face Value
2
Book Value
848.5
ROE
11.39%
EBITDA Growth
748.92 Cr.
Debt/Equity
0.23
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Alkem Laboratories Ltd Quaterly Results
Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
INCOME | 3086.24 | 2971.27 | 3033.56 | 3503.36 | 3417.51 |
PROFIT | 454.71 | 103.91 | 286.73 | 664.03 | 637.37 |
EPS | 38.03 | 5.94 | 23.98 | 51.9 | 49.76 |
Alkem Laboratories Ltd Quaterly Results
Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
INCOME | 2357.46 | 2314.59 | 2317.87 | 2696.43 | 2590.25 |
PROFIT | 388.89 | 254.79 | 271.44 | 646.51 | 546.85 |
EPS | 32.53 | 21.31 | 22.7 | 54.07 | 42.17 |
Profit & Loss (Figures in Rs. Crores)
Alkem Laboratories Ltd Profit & Loss
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | ||
INCOME | 3341.48 | 3958.07 | 5268.99 | 6089.14 | 6611.58 | 7441.25 | 8678.53 | 9432.06 | 11332.32 | 11352.97 | |
PROFIT | 438.34 | 362.81 | 751.53 | 893.54 | 630.55 | 764.73 | 1126.16 | 1554.57 | 1656.06 | 1073.17 | |
EPS | 0 | 0 | 62.92 | 74.45 | 53.4 | 64.71 | 96.14 | 135.32 | 140.55 | 84.22 |
Alkem Laboratories Ltd Profit & Loss
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | ||
INCOME | 2882.27 | 3331.31 | 4236.38 | 4876.75 | 5473.34 | 5695.11 | 6806.75 | 7710.98 | 9390.6 | 9063.11 | |
PROFIT | 442.01 | 337.54 | 709.35 | 884.57 | 715.41 | 801.27 | 1261.35 | 1668.59 | 1539.43 | 1144.71 | |
EPS | 364.67 | 30.02 | 58.57 | 73.87 | 59.88 | 66.9 | 105.76 | 140.95 | 128.92 | 94.9 |
Balance Sheet (Figures in Rs. Crores)
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 11.96 |
Reserves Total | 9,021.38 | 8,613.99 | 7,352.82 | 6,136.76 | 5,415.43 | 4,839.86 | 4,443.73 | 3,668.05 | 2,975.14 | 2,567.39 |
Total Shareholders Funds | 9,045.29 | 8,637.9 | 7,376.73 | 6,160.67 | 5,439.34 | 4,863.77 | 4,467.64 | 3,691.96 | 2,999.05 | 2,579.35 |
Minority Interest | 389.71 | 209.43 | 181.28 | 148.3 | 132.61 | 121.55 | 115.23 | 95.02 | 85.65 | 0 |
Secured Loans | 300.57 | 1,335.32 | 686.3 | 634.43 | 459.27 | 552.14 | 387.15 | 376.59 | 942.34 | 911.83 |
Unsecured Loans | 1,096.11 | 1,332.87 | 1,105.68 | 981.09 | 484.8 | 445.42 | 272.31 | 280.91 | 363.58 | 216.6 |
Total Debt | 1,396.68 | 2,668.19 | 1,791.98 | 1,615.52 | 944.07 | 997.56 | 659.46 | 657.5 | 1,305.92 | 1,128.43 |
Other Liabilities | 544.17 | 340.67 | 259.56 | 318.08 | 187.11 | 164.6 | 113.46 | 85.61 | 75.3 | 55.22 |
Total Liabilities | 11,375.85 | 11,856.19 | 9,609.55 | 8,242.57 | 6,703.13 | 6,147.48 | 5,355.79 | 4,530.09 | 4,465.92 | 3,763 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 4,050.25 | 4,185.6 | 3,768.85 | 3,606.95 | 3,026.09 | 2,603.78 | 1,977.2 | 1,538.64 | 1,744.89 | 1,170.01 |
Less: Accumulated Depreciation | 1,367.42 | 1,283.87 | 975.87 | 698.94 | 495.65 | 320.19 | 180.16 | 89.1 | 370.55 | 0 |
Net Block | 2,682.83 | 2,901.73 | 2,792.98 | 2,908.01 | 2,530.44 | 2,283.59 | 1,797.04 | 1,449.54 | 1,374.34 | 1,170.01 |
Capital Work in Progress | 323.24 | 339.48 | 393.28 | 362.97 | 492.96 | 380.97 | 299.26 | 172.42 | 110.69 | 0 |
Investments | 621.82 | 370.98 | 332.78 | 261.39 | 323.62 | 444.27 | 553 | 508.57 | 480.78 | 588.01 |
Inventories | 2,607.53 | 3,005.53 | 2,312.44 | 1,818.82 | 1,499.87 | 1,442.19 | 1,206 | 909.37 | 784.23 | 620.33 |
Sundry Debtors | 2,132.18 | 1,884.6 | 1,607.21 | 1,649.36 | 1,248.41 | 1,080.5 | 713.64 | 567.51 | 527.08 | 366.93 |
Cash and Bank Balance | 2,616.89 | 2,578.58 | 1,990.45 | 1,092.21 | 661.6 | 576.78 | 399.26 | 780.9 | 790.76 | 206.29 |
Loans and Advances | 1,055.89 | 827.41 | 834.34 | 775.37 | 578.37 | 567.93 | 304.68 | 236.74 | 174.93 | 158.83 |
Total Current Assets | 8,412.49 | 8,296.12 | 6,744.44 | 5,335.76 | 3,988.25 | 3,667.4 | 2,623.58 | 2,494.52 | 2,277 | 1,352.38 |
Current Liabilities | 1,984.61 | 1,923.08 | 1,654.14 | 1,471.42 | 1,348.83 | 1,375.19 | 1,075.09 | 876.62 | 649.07 | 459.05 |
Provisions | 396.19 | 289.92 | 255.57 | 231.55 | 155.93 | 141.29 | 136.7 | 126.94 | 84.42 | 50.35 |
Total Current Liabilities & Provisions | 2,380.8 | 2,213 | 1,909.71 | 1,702.97 | 1,504.76 | 1,516.48 | 1,211.79 | 1,003.56 | 733.49 | 509.4 |
Net Current Assets | 6,031.69 | 6,083.12 | 4,834.73 | 3,632.79 | 2,483.49 | 2,150.92 | 1,411.79 | 1,490.96 | 1,543.51 | 842.98 |
Deferred Tax Assets | 1,498.3 | 1,527.92 | 1,281.97 | 1,099.99 | 1,066.13 | 965.33 | 894.16 | 666.32 | 33.68 | 39 |
Deferred Tax Liability | 195.8 | 218.66 | 174.06 | 167.42 | 358.8 | 311.39 | 198.36 | 151.1 | 125.55 | 78.08 |
Net Deferred Tax | 1,302.5 | 1,309.26 | 1,107.91 | 932.57 | 707.33 | 653.94 | 695.8 | 515.22 | -91.87 | -39.08 |
Other Assets | 413.77 | 851.62 | 147.87 | 144.84 | 165.29 | 233.79 | 598.9 | 393.38 | 1,048.47 | 1,201.08 |
Total Assets | 11,375.85 | 11,856.19 | 9,609.55 | 8,242.57 | 6,703.13 | 6,147.48 | 5,355.79 | 4,530.09 | 4,465.92 | 3,763 |
Contingent Liabilities | 323.79 | 307.47 | 296.33 | 280.91 | 330.58 | 276.75 | 312.33 | 325.62 | 263.06 | 147.39 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 11.96 |
Reserves Total | 9,325.94 | 8,719.75 | 7,601.84 | 6,256.53 | 5,441.3 | 4,861.45 | 4,368.74 | 3,575.59 | 3,077.11 | 2,703 |
Total Shareholders Funds | 9,349.85 | 8,743.66 | 7,625.75 | 6,280.44 | 5,465.21 | 4,885.36 | 4,392.65 | 3,599.5 | 3,101.02 | 2,714.96 |
Secured Loans | 119.31 | 1,010.07 | 327.88 | 238.6 | 32.38 | 110.71 | 108 | 151.06 | 883.24 | 730.47 |
Unsecured Loans | 1,062.38 | 1,283.71 | 1,055.63 | 970.78 | 470.58 | 436.81 | 260.23 | 229.21 | 219.3 | 216.6 |
Total Debt | 1,181.69 | 2,293.78 | 1,383.51 | 1,209.38 | 502.96 | 547.52 | 368.23 | 380.27 | 1,102.54 | 947.07 |
Other Liabilities | 291.48 | 263.91 | 197.35 | 239.31 | 150.75 | 135.8 | 92.35 | 68.62 | 60.09 | 47.35 |
Total Liabilities | 10,823.02 | 11,301.35 | 9,206.61 | 7,729.13 | 6,118.92 | 5,568.68 | 4,853.23 | 4,048.39 | 4,263.65 | 3,709.38 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 2,932.25 | 2,826.98 | 2,481.89 | 2,351.73 | 1,973.17 | 1,713.69 | 1,262.9 | 944.72 | 1,156.17 | 909.39 |
Less : Accumulated Depreciation | 1,107.16 | 944.91 | 723.53 | 514.97 | 366.79 | 242.7 | 137.27 | 70.04 | 285.71 | 0 |
Net Block | 1,825.09 | 1,882.07 | 1,758.36 | 1,836.76 | 1,606.38 | 1,470.99 | 1,125.63 | 874.68 | 870.46 | 909.39 |
Capital Work in Progress | 228.75 | 232.45 | 323.26 | 313.66 | 381.59 | 298.92 | 218.44 | 146.55 | 95.89 | 0 |
Investments | 3,005.55 | 2,528.61 | 2,152.38 | 1,956.04 | 1,695.6 | 1,544.5 | 1,517.64 | 1,157.67 | 1,070.56 | 939.99 |
Inventories | 1,724.66 | 1,975.73 | 1,513.26 | 1,092.58 | 991.28 | 1,024.16 | 858.76 | 590.03 | 548.24 | 504.56 |
Sundry Debtors | 1,768.34 | 1,768.22 | 1,556.55 | 1,555.07 | 966.64 | 875 | 633.32 | 480.44 | 375.01 | 290.32 |
Cash and Bank Balance | 2,163.87 | 2,297.21 | 1,673.36 | 765.61 | 397.94 | 278.3 | 199.06 | 524.03 | 633.32 | 122.76 |
Loans and Advances | 802.75 | 684.29 | 726.2 | 654.4 | 505.64 | 513.15 | 284.89 | 211.98 | 160.81 | 152.96 |
Total Current Assets | 6,459.62 | 6,725.45 | 5,469.37 | 4,067.66 | 2,861.5 | 2,690.61 | 1,976.03 | 1,806.48 | 1,717.38 | 1,070.6 |
Current Liabilities | 1,683.76 | 1,673.8 | 1,367.46 | 1,207.97 | 1,041.45 | 1,143.03 | 941.16 | 684.39 | 461.99 | 397.96 |
Provisions | 224.44 | 194.02 | 198.66 | 168.73 | 131.78 | 102.46 | 103.96 | 89.63 | 66.65 | 50.16 |
Total Current Liabilities & Provisions | 1,908.2 | 1,867.82 | 1,566.12 | 1,376.7 | 1,173.23 | 1,245.49 | 1,045.12 | 774.02 | 528.64 | 448.12 |
Net Current Assets | 4,551.42 | 4,857.63 | 3,903.25 | 2,690.96 | 1,688.27 | 1,445.12 | 930.91 | 1,032.46 | 1,188.74 | 622.48 |
Deferred Tax Assets | 1,292.75 | 1,248.66 | 1,143.51 | 1,005.92 | 835.63 | 759.87 | 753.12 | 555.95 | 29.2 | 34.02 |
Deferred Tax Liability | 207.83 | 199.92 | 189.08 | 186.76 | 199.04 | 181.82 | 162.12 | 146.56 | 97.71 | 78.08 |
Net Deferred Tax | 1,084.92 | 1,048.74 | 954.43 | 819.16 | 636.59 | 578.05 | 591 | 409.39 | -68.51 | -44.06 |
Other Assets | 127.29 | 751.85 | 114.93 | 112.55 | 110.49 | 231.1 | 469.61 | 427.64 | 1,106.51 | 1,281.58 |
Total Assets | 10,823.02 | 11,301.35 | 9,206.61 | 7,729.13 | 6,118.92 | 5,568.68 | 4,853.23 | 4,048.39 | 4,263.65 | 3,709.38 |
Contingent Liabilities | 289.53 | 274.92 | 287.75 | 278.73 | 329.43 | 277.3 | 310.82 | 684.87 | 354.94 | 341.97 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 1,304.77 |
Depreciation | 310.42 |
Interest (Net) | -63.78 |
Dividend Received | 0.19 |
P/L on Sales of Assets | 12.36 |
P/L on Sales of Invest | -2.16 |
Prov. and W/O (Net) | 108.28 |
P/L in Forex | -40.58 |
Total Adjustments (PBT and Ext... | 324.35 |
Operating Profit before Workin... | 1,629.12 |
Trade and 0ther Receivables | -134.71 |
Inventories | 473.41 |
Trade Payables | 14.51 |
Loans and Advances | -77.01 |
Total Adjustments (OP before W... | 326.77 |
Cash Generated from/(used in) ... | 1,955.89 |
Direct Taxes Paid | -273.39 |
Total Adjustments(Cash Generat... | -273.39 |
Cash Flow before Extraordinary... | 1,682.5 |
Net Cash from Operating Activi... | 1,682.5 |
Purchased of Fixed Assets | -232.91 |
Sale of Fixed Assets | 3.2 |
Purchase of Investments | -217.53 |
Interest Received | 146.91 |
Net Cash used in Investing Act... | 119.94 |
Proceed from Issue of Debentur... | 161.48 |
Of the Long Tem Borrowings | -9.5 |
Of the Short Term Borrowings | -1,268.98 |
Of Financial Liabilities | -23.84 |
Dividend Paid | -529.52 |
Interest Paid | -90.46 |
Net Cash used in Financing Act... | -1,760.82 |
Net Profit before Tax and Extr... | 1,326.99 |
Depreciation | 229.85 |
Interest (Net) | -60.78 |
Dividend Received | 3.63 |
P/L on Sales of Assets | 12.36 |
P/L on Sales of Invest | -1.93 |
Prov. and W/O (Net) | 1.54 |
P/L in Forex | -15.54 |
Total Adjustments (PBT and Ext... | 128.89 |
Operating Profit before Workin... | 1,455.88 |
Trade and 0ther Receivables | 1.92 |
Inventories | 251.07 |
Trade Payables | 8.26 |
Loans and Advances | -83.85 |
Total Adjustments (OP before W... | 205.7 |
Cash Generated from/(used in) ... | 1,661.58 |
Direct Taxes Paid | -224.16 |
Total Adjustments(Cash Generat... | -224.16 |
Cash Flow before Extraordinary... | 1,437.42 |
Net Cash from Operating Activi... | 1,437.42 |
Purchased of Fixed Assets | -141.78 |
Sale of Fixed Assets | 2.76 |
Purchase of Investments | -168.79 |
Interest Received | 122.95 |
Invest.In Subsidiaires | -273.24 |
Net Cash used in Investing Act... | 197.04 |
Of the Short Term Borrowings | -1,102.95 |
Of Financial Liabilities | -12.62 |
Dividend Paid | -526.09 |
Interest Paid | -69.61 |
Net Cash used in Financing Act... | -1,711.27 |
Company Details
Registered Office |
|
Address | Alkem House SenapatiBapat Marg, Lower Parel |
City | Mumbai |
State | Maharashtra |
Pin Code | 400013 |
Tel. No. | 91-22-39829999 |
Fax. No. | 91-22-24952955 |
investors@alkem.com ; contact@alkem.com | |
Internet | http://www.alkemlabs.com |
Registrars |
|
Address | Alkem House SenapatiBapat Marg |
City | Mumbai |
State | Maharashtra |
Pin Code | 400013 |
Tel. No. | 91-22-39829999 |
Fax. No. | 91-22-24952955 |
investors@alkem.com ; contact@alkem.com | |
Internet | http://www.alkemlabs.com |
Management |
|
Name | Designation |
Basudeo N Singh | Executive Chairman |
SANDEEP SINGH | Managing Director |
Mritunjay Kumar Singh | Executive Director |
A K Purwar | Non-Exec. & Independent Dir. |
SANGEETA KAPILJIT SINGH | Non-Exec. & Independent Dir. |
SUDHA RAVI | Non-Exec. & Independent Dir. |
Manish Narang | Company Sec. & Compli. Officer |
Dheeraj Sharma | Non-Exec. & Independent Dir. |
Narendra Aneja | Non-Exec. & Independent Dir. |
SARVESH SINGH | Executive Director |
Madhurima Singh | Executive Director |
Sujjain Talwar | Independent Director |
Srinivas Singh | Executive Director |